US agrees to review new Moderna flu vaccine
Moderna has announced that the FDA has reversed its decision and will analyze its new flu vaccine, which uses mRNA technology.
Hope Against Triple Negative Breast Cancer: Experimental Vaccine Shows Positive Results
An experimental mRNA vaccine shows promising outcomes in a small trial for triple-negative breast cancer patients.
FDA reverses course and will review Moderna’s mRNA-based flu vaccine
The FDA has decided to review Moderna's application for its mRNA-based flu vaccine after initially declining it, responding to criticism regarding its decision-making processes.
Personalized vaccine against triple-negative breast cancer could change treatment in Mexico
A new personalized mRNA vaccine being developed in Mexico may transform treatment for triple-negative breast cancer, a particularly aggressive subtype of the disease.
Leader: Because of Trump, there might be no vaccine for cancer
The article discusses how Donald Trump's political actions in the U.S. may impede the development of a promising cancer vaccine based on mRNA technology.
FDA refuses to consider Moderna flu shot in move experts claim is part of ‘anti-vaccine agenda’
The FDA declined to review Moderna's mRNA flu vaccine application, prompting concerns that the decision may be influenced by anti-vaccine sentiment rather than scientific rigor.
Moderna claims that the US refuses to review the mRNA-based flu vaccine
Moderna asserts that the US FDA has declined to review its mRNA-based flu vaccine due to concerns over inadequate clinical trials and lack of proper comparison with existing products.
FDA refuses to review Moderna’s mRNA flu vaccine application
The FDA has declined to review Moderna's mRNA flu vaccine application, potentially delaying its introduction for older adults.
FDA declines to review Moderna application for new flu vaccine
US regulators have refused to review Moderna's request for a new flu vaccine, raising concerns about the future of flu vaccination efforts in the country.
Great Expectations for Vaccine Against Advanced Lung Cancer: What the Director of St. Savvas Oncology Says
The director of St. Savvas Oncology, Alexandros Ardavani, expresses optimism regarding an mRNA therapeutic vaccine currently undergoing trials for advanced lung cancer.